The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

• Conditions: SARS-CoV-2; Covid 19
• Interventions: Dietary Supplement: NRICM101

• Registration Number: NCT04664049
• Lead Sponsor: National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Brief Summary

Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).

Detailed Description

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is raging around the world. Because of its strong spread, variability, survivability, and invisibility, the number of infected people rise rapidly. On March 11, 2020, the WHO officially declared COVID-19 as a pandemic disease. As of October 3, 2020, the number of confirmed cases has exceeded 34 million, and the cumulative deaths have exceeded 1 million. There are still no drugs to treatment the coronavirus disease 2019 (COVID-19). Due to the mutation of virus rapidly, vaccine development cannot be completed in a short period of time. At the beginning of the infection outbreak, the governments of China and South Korea, adopted a cooperative of Chinese and Western medicine to treatment the coronavirus disease 2019 (COVID-19). In addition to the reported good clinical effects, Chinese medicine prescriptions have included in diagnosis and treatment guideline of these two countries.

Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).

Study Timeline

• Study First Submitted: 2020-12-04
• Study First Submitted QC: 2020-12-09
• Study First Posted: 2020-12-11
• Study Start: 2020-12-23
• Status Verified: 2021-01
• Last Update Submitted: 2021-01-11
• Last Update Posted: 2021-01-13
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 51000

Inclusion Criteria

• Subjects who confirmed, suspected or prevented infected of COVID 19 disease and take dietary supplement NRICM101

Exclusion Criteria

• Those who refuse to participate in observational research.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
NRICM101	NRICM101	Subjects who confirmed, suspected or prevented infected of COVID 19 disease and received dietary supplement NRICM101

Primary Outcome Measures

Name	Time	Method
negative of COVID-19 test	1 day to 2 months	receive COVID 19 test and the result is negative
free of COVID 19 disease symptoms and signs	1 day to 2 months	free of COVID 19 disease symptoms and signs after took NRICM101

Trial Locations

Locations (1)

National Research Institute of Chinese Medicine, Ministry of Health and Welfare; 🇨🇳 Taipei, Taiwan